Image

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Trial of NMS-03597812 for adults with recurring acute myeloid leukemia.

Recruiting
18 years and older
All
Phase 1
This study is for adults with **Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)**, a type of blood cancer that has returned or didn’t respond to treatment. The study checks the safety and effects of a new drug, **NMS-03597812**, for patients who have tried all other treatments. Some patients may have a specific genetic mutation called **TP53**. In the future, the drug might be tested with another medicine called **venetoclax**. Here’s what you need to know: - **Participation:** You'll take the drug as a capsule and may need to visit the doctor regularly for check-ups and tests. - **Safety:** The study will watch for side effects, and you’ll need to agree to use birth control if needed. - **Eligibility:** You must be an adult (18+), able to swallow pills, and not have certain other health issues like specific leukemias or recent surgeries. Before joining, you’ll discuss the potential benefits and risks with your doctor and sign a form to show you understand the study. If you are interested, make sure you meet all the study requirements and are willing to follow the study plan. **Note:** Other specific rules might apply to see if you qualify.
Study details
    Relapsed/Refractory Acute Myeloid Leukemia

NCT06549790

Nerviano Medical Sciences

22 February 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.